gliclazide and Leishmaniasis, Visceral

gliclazide has been researched along with Leishmaniasis, Visceral in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Das, PK; Ghosh, K; Kar, S; Srivastav, S; Ukil, A	1

Other Studies

1 other study(ies) available for gliclazide and Leishmaniasis, Visceral

Article	Year
Curative effect of 18β-glycyrrhetinic acid in experimental visceral leishmaniasis depends on phosphatase-dependent modulation of cellular MAP kinases. PloS one, 2011, Volume: 6, Issue:12 Topics: Animals; Cytokines; Glycyrrhetinic Acid; Leishmania donovani; Leishmaniasis, Visceral; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Parasitemia; Phosphoprotein Phosphatases; Spleen; Th1 Cells; Up-Regulation	2011

Article

Year

Curative effect of 18β-glycyrrhetinic acid in experimental visceral leishmaniasis depends on phosphatase-dependent modulation of cellular MAP kinases.

PloS one, 2011, Volume: 6, Issue:12

Topics: Animals; Cytokines; Glycyrrhetinic Acid; Leishmania donovani; Leishmaniasis, Visceral; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Parasitemia; Phosphoprotein Phosphatases; Spleen; Th1 Cells; Up-Regulation

2011